Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Conscious Cogn ; 100: 103317, 2022 04.
Article in English | MEDLINE | ID: mdl-35364385

ABSTRACT

AIM: This study investigated the bromazepam effects in male subjects during the time estimation performance and EEG alpha asymmetry in electrodes associated with the frontal and motor cortex. MATERIAL AND METHODS: This is a double-blind, crossover study with a sample of 32 healthy adults under control (placebo) vs. experimental (bromazepam) during visual time-estimation task in combination with electroencephalographic analysis. RESULTS: The results demonstrated that the bromazepam increased the relative error in the 4 s, 7 s, and 9 s intervals (p = 0.001). In addition, oral bromazepam modulated the EEG alpha asymmetry in cortical areas during the time judgment (p ≤ 0.025). CONCLUSION: The bromazepam decreases the precision of time estimation judgments and modulates the EEG alpha asymmetry, with greater left hemispheric dominance during time perception. Our findings suggest that bromazepam influences internal clock synchronization via the modulation of GABAergic receptors, strongly relating to attention, conscious perception, and behavioral performance.


Subject(s)
Bromazepam , Time Perception , Adult , Bromazepam/pharmacology , Cross-Over Studies , Double-Blind Method , Electroencephalography/methods , Humans , Judgment , Male
2.
Carbohydr Polym ; 152: 140-148, 2016 Nov 05.
Article in English | MEDLINE | ID: mdl-27516258

ABSTRACT

A sulfated polysaccharide (SFP) fraction from the marine alga Solieria filiformis was extracted and submitted to microanalysis, molar mass estimation and spectroscopic analysis. We evaluated its gastroprotective potential in vivo in an ethanol-induced gastric damage model and its in vitro antioxidant properties (DPPH, chelating ferrous ability and total antioxidant capacity). Its chemical composition revealed to be essentially an iota-carrageenan with a molar mass of 210.9kDa and high degree of substitution for sulfate groups (1.08). In vivo, SFP significantly (P<0.05) reduced, in a dose dependent manner, the ethanol-induced gastric damage. SFP prevents glutathione consume and increase of malondialdehyde and hemoglobin levels. SFP presented an IC50 of 1.77mg/mL in scavenging DPPH. The chelating ferrous ability was 38.98%, and the total antioxidant capacity was 2.01mg/mL. Thus, SFP prevents the development of ethanol-induced gastric damage by reducing oxidative stress in vivo and possesses relevant antioxidant activity in vitro.


Subject(s)
Antioxidants , Oxidative Stress/drug effects , Polysaccharides , Rhodophyta/chemistry , Stomach Diseases/prevention & control , Animals , Antioxidants/chemistry , Antioxidants/isolation & purification , Antioxidants/pharmacology , Ethanol/toxicity , Mice , Polysaccharides/chemistry , Polysaccharides/isolation & purification , Polysaccharides/pharmacology , Stomach Diseases/chemically induced
3.
Inflammation ; 37(5): 1826-36, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24803298

ABSTRACT

The aim of this study was to investigate the potential anti-inflammatory and anti-oxidant effects of gabapentin (GBP) in mice. The anti-inflammatory and anti-oxidant effects were evaluated using various mediators that induce paw edema, peritonitis model, myeloperoxidase (MPO) activity, proinflammatory cytokine levels, glutathione (GSH) consumption, and malondialdehyde (MDA) production in mice. Pretreatment of mice with GBP (1 mg/kg) significantly reduced carrageenan or dextran-induced paw edema (P<0.05) when compared to vehicle group. Adding to this, GBP (1 mg/kg) significantly inhibited paw edema induced by histamine, serotonin, bradikinin, 48/80 compound, and prostaglandin E2. In the carrageenan-induced peritonitis model, GBP significantly decreased total and differential leukocyte counts and reduced the levels of MPO activity in the plantar tissue and IL-1ß and TNF-α concentrations in the peritoneal exudate. The same dose of GBP also decreased the MDA concentration and increased the levels of GSH into the peritoneal fluid. In summary, our results demonstrated that GBP exhibited anti-inflammatory activity in mice by reducing the action of inflammatory mediators, neutrophil migration and proinflammatory cytokine levels, and anti-oxidant properties by decreasing the concentration of MDA and increasing the GSH content. These observations raise the possibility that GBP could be used to improve tissue resistance to damage during inflammatory conditions.


Subject(s)
Amines/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Cyclohexanecarboxylic Acids/therapeutic use , Edema/drug therapy , Edema/metabolism , Oxidative Stress/drug effects , gamma-Aminobutyric Acid/therapeutic use , Acute Disease , Amines/pharmacology , Animals , Anti-Inflammatory Agents/pharmacology , Cyclohexanecarboxylic Acids/pharmacology , Edema/chemically induced , Gabapentin , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/metabolism , Male , Mice , Oxidative Stress/physiology , Random Allocation , gamma-Aminobutyric Acid/analogs & derivatives , gamma-Aminobutyric Acid/pharmacology
4.
Nitric Oxide ; 40: 22-30, 2014 Aug 31.
Article in English | MEDLINE | ID: mdl-24831353

ABSTRACT

Chronic use of alendronate has been linked to gastrointestinal tract problems. Our objective was to evaluate the role of the NO/cGMP/KATP signaling pathway and nitric oxide synthase expression in alendronate-induced gastric damage. Rats were either treated with the NO donor, sodium nitroprusside (SNP; 1, 3, and 10 mg/kg), or the NO synthase (NOS) substrate, L-arginine (L-Arg; 50, 100, and 200 mg/kg). Some rats were pretreated with either ODQ (a guanylate cyclase inhibitor; 10 mg/kg) or glibenclamide (KATP channels blocker; 10 mg/kg). In other experiments, rats were pretreated with L-NAME (non-selective NOS inhibitor; 10 mg/kg), 1400 W (selective inducible NOS [iNOS] inhibitor; 10 mg/kg), or L-NIO (a selective endothelial NOS [eNOS] inhibitor; 30 mg/kg). After 1 h, the rats were treated with alendronate (30 mg/kg) by gavage for 4 days. SNP and L-Arg prevented alendronate-induced gastric damage in a dose-dependent manner. Alendronate reduced nitrite/nitrate levels, an effect that was reversed with SNP or L-Arg treatment. Pretreatment with ODQ or glibenclamide reversed the protective effects of SNP and L-Arg. L-NAME, 1400 W, or L-NIO aggravated the severity of alendronate-induced lesions. In addition, alendronate reduced the expression of iNOS and eNOS in the gastric mucosa. Gastric ulcerogenic responses induced by alendronate were mediated by a decrease in NO derived from both eNOS and iNOS. In addition, our findings support the hypothesis that activation of the NO/cGMP/KATP pathway is of primary importance for protection against alendronate-induced gastric damage.


Subject(s)
Alendronate/pharmacology , Cyclic GMP/metabolism , KATP Channels/metabolism , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide/metabolism , Stomach Ulcer/chemically induced , Administration, Oral , Alendronate/administration & dosage , Animals , Dose-Response Relationship, Drug , Female , Nitric Oxide Synthase/biosynthesis , Nitric Oxide Synthase/metabolism , Rats , Rats, Wistar , Signal Transduction , Stomach Ulcer/enzymology , Stomach Ulcer/metabolism , Structure-Activity Relationship
5.
Carbohydr Polym ; 108: 17-25, 2014 Aug 08.
Article in English | MEDLINE | ID: mdl-24751242

ABSTRACT

Polysaccharides (PLS) have notably diverse pharmacological properties. In the present study, we investigated the previously unexplored anti-inflammatory and antinociceptive activities of the PLS fraction isolated from the marine red alga Digenea simplex. We found that the PLS fraction reduced carrageenan-induced edema in a dose-dependent manner, and inhibited inflammation induced by dextran, histamine, serotonin, and bradykinin. The fraction also inhibited neutrophil migration into both mouse paw and peritoneal cavity. This effect was accompanied by decreases in IL1-ß and TNF-α levels in the peritoneal fluid. Pre-treatment of mice with PLS (60 mg/kg) significantly reduced acetic acid-induced abdominal writhing. This same dose of PLS also reduced total licking time in both phases of a formalin test, and increased latency in a hot plate test. Therefore, we conclude that PLS extracted from D. simplex possess anti-inflammatory and antinociceptive activities and can be useful as therapeutic agents against inflammatory diseases.


Subject(s)
Analgesics/chemistry , Analgesics/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Polysaccharides/chemistry , Polysaccharides/therapeutic use , Rhodophyta/chemistry , Acetic Acid/toxicity , Animals , Anti-Inflammatory Agents/chemistry , Carrageenan/toxicity , Edema/chemically induced , Edema/drug therapy , Interleukin-1beta/metabolism , Male , Mice , Pain/chemically induced , Pain/drug therapy , Tumor Necrosis Factor-alpha/metabolism
6.
Life Sci ; 94(1): 58-66, 2014 Jan 14.
Article in English | MEDLINE | ID: mdl-24239641

ABSTRACT

AIMS: The present study aimed to investigate the potential anti-inflammatory and anti-nociceptive effects of carvacryl acetate, a derivative of carvacrol, in mice. MAIN METHODS: The anti-inflammatory activity was evaluated using various phlogistic agents that induce paw edema, peritonitis model, myeloperoxidase (MPO) activity, pro and anti-inflammatory cytokine levels. Evaluation of antinociceptive activity was conducted through acetic acid-induced writhing, hot plate test, formalin test, capsaicin and glutamate tests, as well as evaluation of motor performance on rotarod test. KEY FINDINGS: Pretreatment of mice with carvacryl acetate (75 mg/kg) significantly reduced carrageenan-induced paw edema (P<0.05) when compared to vehicle-treated group. Likewise, carvacryl acetate (75 mg/kg) strongly inhibited edema induced by histamine, serotonin, prostaglandin E2 and compound 48/80. In the peritonitis model, carvacryl acetate significantly decreased total and differential leukocyte counts, and reduced levels of myeloperoxidase and interleukin-1 beta (IL-1ß) in the peritoneal exudate. The levels of IL-10, an anti-inflammatory cytokine, were enhanced by carvacryl acetate. Pretreatment with carvacryl acetate also decreased the number of acetic acid-induced writhing, increased the latency time of the animals on the hot plate and decreased paw licking time in the formalin, capsaicin and glutamate tests. The pretreatment with naloxone did not reverse the carvacryl acetate-mediated nociceptive effect. SIGNIFICANCE: In conclusion, the current study demonstrated that carvacryl acetate exhibited anti-inflammatory activity in mice by reducing inflammatory mediators, neutrophil migration and cytokine concentration, and anti-nociceptive activity due to the involvement of capsaicin and glutamate pathways.


Subject(s)
Analgesics/pharmacology , Anti-Inflammatory Agents/pharmacology , Inflammation/drug therapy , Monoterpenes/pharmacology , Pain/drug therapy , Animals , Cytokines/metabolism , Disease Models, Animal , Edema/drug therapy , Edema/physiopathology , Immune System Diseases/drug therapy , Inflammation/physiopathology , Inflammation Mediators/metabolism , Leukocyte Disorders/drug therapy , Male , Mice , Pain/physiopathology , Peritonitis/drug therapy , Peritonitis/physiopathology , Peroxidase/drug effects , Peroxidase/metabolism
7.
Neurosci Lett ; 556: 93-8, 2013 Nov 27.
Article in English | MEDLINE | ID: mdl-24140003

ABSTRACT

Gabapentin (GBP) is an anti-convulsive drug often used as analgesic to control neuropathic pain. This study aimed at evaluating whether oral GBP treatment could improve nerve inflammation response after sciatic nerve constriction in association with selected pain and motor spontaneous behavior assessments in Wistar rats. We evaluated nerve myeloperoxidase (MPO) and inflammatory cytokines on the 5th day post-injury, time in which nerve inflammation is ongoing. In addition, the role of GBP on carrageenan-induced paw edema and peritoneal cell migration was analyzed. GBP was given by gavage at doses of 30, 60 and 120mg/kg, 60min prior to chronic constriction of the sciatic nerve (CCSN) and during 5 days post-injury, 12/12h. CCSN animals treated with saline were used as controls and for behavioral and inflammation assessments untreated sham-operated rats were also used. On the 5th day, GBP (60 and 120mg/kg) alleviated heat-induced hyperalgesia and significantly increased delta walking scores in CCSN animals, the latter suggesting excitatory effects rather than sedation. GBP (60mg/kg) significantly increased nerve MPO, TNF-α, and IL-1ß levels, comparing with the saline group. GBP (120mg/kg) reduced the anti-inflammatory cytokine IL-10 nerve levels compared with the CCSN saline group. Furthermore, GBP (60 and 120mg/kg) increased carrageenan-induced paw edema and peritoneal macrophage migration compared with the CCSN saline group. Altogether our findings suggest that GBP accentuates nerve and peripheral inflammatory response, however confirmed its analgesic effect likely due to an independent CNS-mediated mechanism, and raise some concerns about potential GBP inflammatory side effects in widespread clinical use.


Subject(s)
Amines/pharmacology , Analgesics/pharmacology , Cyclohexanecarboxylic Acids/pharmacology , Edema/drug therapy , Neuralgia/drug therapy , Sciatic Nerve/drug effects , gamma-Aminobutyric Acid/pharmacology , Administration, Oral , Amines/administration & dosage , Amines/therapeutic use , Analgesics/administration & dosage , Analgesics/therapeutic use , Animals , Cell Movement , Constriction, Pathologic , Cyclohexanecarboxylic Acids/administration & dosage , Cyclohexanecarboxylic Acids/therapeutic use , Cytokines/metabolism , Edema/immunology , Gabapentin , Inflammation/drug therapy , Inflammation/immunology , Male , Motor Activity/drug effects , Neuralgia/immunology , Neuralgia/physiopathology , Peritoneal Cavity/cytology , Rats , Rats, Wistar , Sciatic Nerve/immunology , Sciatic Nerve/injuries , gamma-Aminobutyric Acid/administration & dosage , gamma-Aminobutyric Acid/therapeutic use
8.
Eur J Pharmacol ; 693(1-3): 57-63, 2012 Oct 15.
Article in English | MEDLINE | ID: mdl-22884438

ABSTRACT

Hydrogen sulphide (H(2)S) has shown to relax gastrointestinal muscle. Here in, we evaluated the effects of H(2)S donors on gastric emptying and in pyloric sphincter muscle relaxation, and whether these effects involved K(ATP) channels or TRPV1 receptors. Mice were treated with l-cysteine (alone or with propargylglycine-an inhibitor of H(2)S synthesis), NaHS, Lawesson's reagent (H(2)S donors) or saline. After 30 min, mice were gavaged with a liquid meal containing a nonabsorbable marker and then killed at 10, 20 or 30 min intervals to assess marker recovery from the stomach and intestine. This experiment was repeated in mice pre-treated with K(ATP) channel (glibenclamide) or TRPV1 receptor (capsazepine) antagonists. In addition, pyloric sphincter muscles were mounted in an organ bath, incubated with saline, glibenclamide or capsazepine, and NaHS dose-responses were determined. H(2)S donors and l-cysteine enhanced gastric emptying in a dose-dependent manner; propargylglycine reversed the effect of l-cysteine. Both glibenclamide and capsazepine abolished l-cysteine and H(2)S donors' augmentation of gastric emptying. Dose-dependent inductions of pyloric sphincter relaxation by NaHS were abolished by glibenclamide or capsazepine. These data suggest that H(2)S donors-induced acceleration of gastric emptying and relaxation of pyloric sphincter muscle by K(ATP) channel and TRPV1 receptor activations.


Subject(s)
Gastric Emptying/physiology , Hydrogen Sulfide , KATP Channels/physiology , TRPV Cation Channels/physiology , Animals , Capsaicin/analogs & derivatives , Capsaicin/pharmacology , Gastric Emptying/drug effects , Glyburide/pharmacology , KATP Channels/antagonists & inhibitors , Male , Mice , Muscle Relaxation/drug effects , Potassium Channel Blockers/pharmacology , Pylorus/drug effects , Pylorus/physiology , TRPV Cation Channels/antagonists & inhibitors
9.
Mar Drugs ; 10(12): 2618-33, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23342384

ABSTRACT

Red seaweeds synthesize a great variety of sulfated galactans. Sulfated polysaccharides (PLSs) from seaweed are comprised of substances with pharmaceutical and biomedical potential. The aim of the present study was to evaluate the protective effect of the PLS fraction extracted from the seaweed Gracilaria birdiae in rats with naproxen-induced gastrointestinal damage. Male Wistar rats were pretreated with 0.5% carboxymethylcellulose (control group-vehicle) or PLS (10, 30, and 90 mg/kg, p.o.) twice daily (at 09:00 and 21:00) for 2 days. After 1 h, naproxen (80 mg/kg, p.o.) was administered. The rats were killed on day two, 4 h after naproxen treatment. The stomachs were promptly excised, opened along the greater curvature, and measured using digital calipers. Furthermore, the guts of the animals were removed, and a 5-cm portion of the small intestine (jejunum and ileum) was used for the evaluation of macroscopic scores. Samples of the stomach and the small intestine were used for histological evaluation, morphometric analysis and in assays for glutathione (GSH) levels, malonyldialdehyde (MDA) concentration, and myeloperoxidase (MPO) activity. PLS treatment reduced the macroscopic and microscopic naproxen-induced gastrointestinal damage in a dose-dependent manner. Our results suggest that the PLS fraction has a protective effect against gastrointestinal damage through mechanisms that involve the inhibition of inflammatory cell infiltration and lipid peroxidation.


Subject(s)
Gastrointestinal Diseases/prevention & control , Gracilaria/chemistry , Polysaccharides/pharmacology , Animals , Dose-Response Relationship, Drug , Gastrointestinal Diseases/chemically induced , Glutathione/metabolism , Inflammation/chemically induced , Inflammation/prevention & control , Lipid Peroxidation/drug effects , Male , Malondialdehyde/metabolism , Naproxen/toxicity , Peroxidase/metabolism , Polysaccharides/administration & dosage , Polysaccharides/isolation & purification , Rats , Rats, Wistar
10.
J Pharmacol Exp Ther ; 330(3): 764-70, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19491326

ABSTRACT

The aim of this study was to evaluate the protective effect of hydrogen sulfide (H(2)S) on ethanol-induced gastric lesions in mice and the influence of ATP-sensitive potassium (K(ATP)) channels, capsaicin-sensitive sensory afferent neurons, and transient receptor potential vanilloid (TRPV) 1 receptors on such an effect. Saline and L-cysteine alone or with propargylglycine, sodium hydrogen sulfide (NaHS), or Lawesson's reagent were administrated for testing purposes. For other experiments, mice were pretreated with glibenclamide, neurotoxic doses of capsaicin, or capsazepine. Afterward, mice received L-cysteine, NaHS, or Lawesson's reagent. After 30 min, 50% ethanol was administrated by gavage. After 1 h, mice were sacrificed, and gastric damage was evaluated by macroscopic and microscopic analyses. L-cysteine, NaHS, and Lawesson's reagent treatment prevented ethanol-induced macroscopic and microscopic gastric damage in a dose-dependent manner. Administration of propargylglycine, an inhibitor of endogenous H(2)S synthesis, reversed gastric protection induced by L-cysteine. Glibenclamide reversed L-cysteine, NaHS, or Lawesson's reagent gastroprotective effects against ethanol-induced macroscopic damage in a dose-dependent manner. Chemical ablation of sensory afferent neurons by capsaicin reversed gastroprotective effects of L-cysteine or H(2)S donors (NaHS or Lawesson's reagent) in ethanol-induced macroscopic gastric damage. Likewise, in the presence of the TRPV1 antagonist capsazepine, the gastroprotective effects of L-cysteine, NaHS, or Lawesson's reagent were also abolished. Our results suggest that H(2)S prevents ethanol-induced gastric damage. Although there are many mechanisms through which this effect can occur, our data support the hypothesis that the activation of K(ATP) channels and afferent neurons/TRPV1 receptors is of primary importance.


Subject(s)
Air Pollutants/pharmacology , Capsaicin/pharmacology , Central Nervous System Depressants/antagonists & inhibitors , Central Nervous System Depressants/toxicity , Ethanol/antagonists & inhibitors , Ethanol/toxicity , Hydrogen Sulfide/pharmacology , KATP Channels/physiology , Neurons, Afferent/drug effects , Stomach Diseases/chemically induced , Stomach Diseases/prevention & control , Alkynes/pharmacology , Animals , Cysteine/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Gastric Mucosa/pathology , Glutathione/metabolism , Glyburide/pharmacology , Glycine/analogs & derivatives , Glycine/pharmacology , Hypoglycemic Agents/pharmacology , KATP Channels/drug effects , Male , Malondialdehyde/metabolism , Mice , Protective Agents/pharmacology , Stomach Diseases/pathology , TRPV Cation Channels/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...